Renaissance Technologies (RenTech)'s WHWK Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 413,822 shares of Whitehawk Therapeutics, Inc. (WHWK) worth $1.9 M, representing 0.00% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in WHWK, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 152,800 shares. Largest reduction occurred in Q2 2023, reducing 121,602 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Whitehawk Therapeutics (WHWK) Holding Value Over Time
Track share changes against reported price movement
Quarterly Whitehawk Therapeutics (WHWK) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -14,800 | Reduce 3.45% | 413,822 | $4.58 |
| Q1 2026 | -12,100 | Reduce 2.75% | 428,622 | $3.45 |
| Q4 2025 | -16,700 | Reduce 3.65% | 440,722 | $2.42 |
| Q3 2025 | -800 | Reduce 0.17% | 457,422 | $1.90 |
| Q2 2025 | -3,900 | Reduce 0.84% | 458,222 | $1.87 |
| Q1 2025 | +6,100 | Add 1.34% | 462,122 | $1.78 |
| Q4 2024 | -5,800 | Reduce 1.26% | 456,022 | $3.16 |
| Q3 2024 | +22,600 | Add 5.15% | 461,822 | $2.06 |
| Q2 2024 | -104,500 | Reduce 19.22% | 439,222 | $1.46 |
| Q1 2024 | +145,000 | Add 36.37% | 543,722 | $2.34 |
| Q4 2023 | +152,800 | Add 62.13% | 398,722 | $2.02 |
| Q3 2023 | +41,800 | Add 20.48% | 245,922 | $4.84 |
| Q2 2023 | -121,602 | Reduce 37.33% | 204,122 | $0.01 |
| Q1 2023 | +74,502 | Add 29.66% | 325,724 | $0.01 |
| Q4 2022 | +7,300 | Add 2.99% | 251,222 | $0.01 |
| Q3 2022 | +70,400 | Add 40.57% | 243,922 | $14.13 |
| Q2 2022 | +34,000 | Add 24.37% | 173,522 | $12.32 |
| Q1 2022 | +11,000 | Add 8.56% | 139,522 | $16.97 |
| Q4 2021 | -37,133 | Reduce 22.42% | 128,522 | $24.15 |
| Q3 2021 | +165,655 | New Buy | 165,655 | $29.37 |
Renaissance Technologies (RenTech)'s Whitehawk Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Whitehawk Therapeutics, Inc. (WHWK) in Q3 2021, acquiring 165,655 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Whitehawk Therapeutics, Inc. (WHWK) for 20 quarters since Q3 2021.
Renaissance Technologies (RenTech)'s largest addition to Whitehawk Therapeutics, Inc. (WHWK) was in Q3 2021, adding 165,655 shares worth $4.86 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 413,822 shares of Whitehawk Therapeutics, Inc. (WHWK), valued at approximately $1.9 M.
As of the Q2 2026 filing, Whitehawk Therapeutics, Inc. (WHWK) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Whitehawk Therapeutics, Inc. (WHWK) was 543,722 shares, as reported at the end of Q1 2024.